GENE ONLINE|News &
Opinion
Blog

2025-11-29|

Study Identifies Procedural Memory Network Changes in Neuropsychiatric Disorders Using rs-fMRI

by GOAI
Share To

Researchers have identified significant changes in the brain’s procedural memory network associated with neuropsychiatric disorders, according to a recent study. The team, led by Mohammadkhanloo et al., employed advanced resting-state functional magnetic resonance imaging (rs-fMRI) and graph theory analysis to investigate the intricate dynamics of these neural networks. Their findings provide new insights into how such disorders may alter brain connectivity and function.

The study utilized rs-fMRI to observe brain activity during rest, focusing on the procedural memory network—a system responsible for tasks such as learning motor skills and habits. By applying graph theory analysis, researchers mapped out the connections within this network and identified patterns of disruption linked to neuropsychiatric conditions. These findings contribute to a growing body of research aimed at understanding the neural mechanisms underlying mental health disorders. Further details about the study are available through its publication online.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 29, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
LATEST
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
Janux Therapeutics Shares Halve Despite Positive Phase I Trial Results for Solid Tumor Therapy
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top